13 Best Artificial Intelligence Stocks Under $50 to Buy Now

10. Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)

Share Price as of May 12: $4.33

Number of Hedge Fund Holders: 21

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a clinical-stage biotech company that uses AI and ML to develop novel therapeutics. The company’s AI-driven drug discovery platform is called the Recursion Operating System/OS. This platform, now in its 2.0 iteration, uses multimodal biological data, extensive computational power, and active drug design capabilities to improve drug discovery.

As of May, Recursion has made over $450 million in revenue through 4 key collaborations. These partnerships show the effectiveness of the Recursion OS in identifying novel drug targets and developing promising therapies. The company also received its 4th program option from Sanofi, which is a testament to the success and potential of its joint research efforts utilizing the Recursion OS.

The company also emphasizes that the Recursion OS 2.0 enables it to achieve leading indicators of success, such as faster hypothesis validation and the generation of drug candidates with fewer synthesized molecules. The focus on sharpening its R&D portfolio is directly informed by the insights from the Recursion OS 2.0. It allows Recursion to double down on high-potential programs and decisively deprioritize those that do not meet its criteria.